It's time -- way past time, actually -- for Amazon to move on from Kirk Herbstreit as part of its NFL Thursday Night Football ...

V.F. Corp.'s Q3 fiscal 2025 earnings exceeded expectations, yet shares fell 4% after initial euphoria. Read why I remain ...

A jury has ruled in favor of CHI Health and two health care professionals after a lawsuit alleged medical malpractice in a woman's death.

If there's one thing we didn't expect to find, it's this pair of all-weather hiking boots from The North Face for half off ...

If it’s been more than four hours and your hard-on isn’t going away, you could be suffering from priapism. It’s a serious ...

As we prepare to enter into the Year of the Snake, we take a moment to recognise the unique qualities this zodiac sign ...

Panelists discuss how switching therapies in patients with alopecia areata (AA) is often necessary when initial treatments ...

New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

Silexion Therapeutics shares preclinical data on SIL-204, highlighting tumor reduction in KRAS-driven cancers and sustained drug efficacy for 56+ days.

Let's explore how business leaders can prepare for success amid rising threats despite a formidable landscape.